Bicycle Therapeutics (NASDAQ:BCYC) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a note issued to investors on Saturday, BidAskClub reports. A number of other equities research analysts have also recently weighed in on BCYC. Cantor Fitzgerald started coverage on Bicycle Therapeutics in a research note […]